Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 1, 1999, Pages 25-31

  Harrison, Paul ^a   Robinson, M S C ^a   Mackie, I J ^a   Joseph, J ^a   McDonald, S J ^a   Liesner, R ^b   Savidge, G F ^c   Pasi, J ^d   Machin, S J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Bleeding time; PFA 100 ; Platelet disorders; Platelets; Von Willebrand's disease

Indexed keywords

ACETYLSALICYLIC ACID; GLYCOPROTEIN IB; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; VON WILLEBRAND FACTOR;

ARTICLE; BERNARD SOULIER DISEASE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLANZMANN DISEASE; HEMATOCRIT; HEMOSTASIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STORAGE DISEASE; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; VON WILLEBRAND DISEASE;

EID: 0032919477     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199901000-00004     Document Type: Article

References (11)

1. 1. Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Haemost 1990; 16: 1-20.
2. 2. Kratzer MAA, Born GVR. Simulation of primary hemostasis in vitro. Haemostasis 1985; 5: 357-362.
3. 3. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Haemost 1995; 21 (suppl 2): 106-112.
4. 4. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100 system. Semin Thromb Haemost 1995; 21 (suppl 2): 113-121.
5. 5. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, et al. The platelet function analyzer (PFA-100®): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998; 101: 70-73.
6. 6. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998; 91: 1325-1331.
7. 7. Marshall PW, Williams AJ, Dixon RM, Growcott JW, Warburton S, Armstrong J, et al. A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers. Br J Clin Pharmacol 1997; 44: 151-155.
8. 8. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, et al. PFA-100™: A new method for assessment of platelet dysfunction. Semin Thromb Haemost 1998; 24: 195-202.
9. 9. Heilmann EJ, Kundu SK, Sio R, Garcia C, Gomez R, Christie DJ. Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system. Thromb Res 1997; 87: 159-164.
10. 10. Asherson RA, Kharmashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
11. 11. Kundu SK, Heilmann EJ, Sio R, Garcia C, Ostgaard RA. Characterization of an in vitro platelet function analyser, PFA-100™. Clin Appl Thromb Haemost 1996; 2: 241-249.